Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Top Cited Papers
Open Access
- 9 March 2019
- journal article
- research article
- Published by Elsevier
- Vol. 393 (10180) , 1505-1516
- https://doi.org/10.1016/s0140-6736(18)32213-x
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Selective laser trabeculoplasty: past, present, and futureEye, 2018
- Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trialThe Lancet, 2015
- Longitudinal Changes in Quality of Life and Rates of Progressive Visual Field Loss in Glaucoma PatientsOphthalmology, 2014
- Glaucoma and On-Road Driving PerformanceInvestigative Opthalmology & Visual Science, 2008
- Risk of Falls and Motor Vehicle Collisions in GlaucomaInvestigative Opthalmology & Visual Science, 2007
- Leading causes of certification for blindness and partial sight in England & WalesBMC Public Health, 2006
- The number of people with glaucoma worldwide in 2010 and 2020British Journal of Ophthalmology, 2006
- beta Blockers for glaucoma and excess risk of airways obstruction: population based cohort studyBMJ, 2002
- The Ocular Hypertension Treatment StudyArchives of Ophthalmology (1950), 2002
- Adverse Effects of Topical Antiglaucoma MedicationArchives of Ophthalmology (1950), 1994